Cannabis Sativa, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 21, 2023 at 12:03 pm EDT
Share
Cannabis Sativa, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 0.323197 million compared to USD 0.456088 million a year ago. Net loss was USD 0.332486 million compared to USD 0.350565 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
For the six months, sales was USD 0.668565 million compared to USD 0.879789 million a year ago. Net loss was USD 0.855408 million compared to USD 0.441456 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.01 a year ago.
Cannabis Sativa, Inc. is engaged in telehealth through its 51% owned subsidiary and the licensing of cannabis-related intellectual property (IP), marketing and branding for cannabis-based products and services, operation of cannabis-related technology services, and ancillary business activities. It operates through various subsidiaries, including PrestoCorp, Inc. (PrestoCorp), Wild Earth Naturals, Inc., Kubby Patent and Licenses Limited Liability Company, Hi Brands, International, Inc., Eden Holdings LLC, and iBudtender, Inc., GK Manufacturing and Packaging, Inc. PrestoCorp offers an online telemedicine platform providing customer access to knowledgeable physicians to obtain a medical marijuana recommendation. PrestoCorp uses video conferencing technology to provide a safe and confidential forum for the doctor patient interview in accordance with state regulations governing issuance of medical marijuana cards. It offers services in California, Nevada, New York, Missouri, and Oklahoma.
CANNABIS SATIVA, INC. 
